← All indications
Intraabdominal Infections
Infection within the PERITONEAL CAVITY. A frequent cause is an ANASTOMOTIC LEAK following surgery.
Subtype terms (3)
More specific conditions that are subtypes of Intraabdominal Infections in the MeSH hierarchy.
- Appendicitis
65 drugs (57 approved, 8 experimental)
- Peritonitis
71 drugs (56 approved, 15 experimental)
- Typhlitis
Drugs by status
Approved for this indication (29)
- metronidazole
- avibactam
- aztreonam
- procaine benzylpenicillin
- cefmetazole
- cefotaxime
- cefotetan
- ceftazidime
- cilastatin
- ceftolozane
- doripenem
- eravacycline
- tigecycline
- piperacillin
- relebactam
- ceftriaxone
- sulbactam
- ciprofloxacin
- ticarcillin
- cefoperazone
- meropenem
- trovafloxacin
- clindamycin
- exametazime
- cefepime
- amikacin
- ertapenem
- imipenem
- tazobactam
Phase 4 trials (3)
Phase 3 trials (5)
Phase 2 trials (2)
Phase 1 trials (3)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (18)
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Peninsula Pharmaceuticals
- The Medicines Company
- AstraZeneca
- Bayer
- Cubist
- Sponsor GmbH
- The EMMES Corporation
- Duke University
- Nanjing Medical University
- Wayne State University
- University of Naples Frederico II
- Tianjin Medical University
- European Commission
- Department of Health and Human Services
- University of Campania Luigi Vanvitelli
- University of Picardie Jules Verne
- Iterum Therapeutics
Organization Involved with Phase 2 Indications (10)
Organization Involved with Phase 1 Indications (1)